David Clayton

1.7k total citations
40 papers, 978 citations indexed

About

David Clayton is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Spectroscopy. According to data from OpenAlex, David Clayton has authored 40 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Pathology and Forensic Medicine and 7 papers in Spectroscopy. Recurrent topics in David Clayton's work include Advanced MRI Techniques and Applications (15 papers), Multiple Sclerosis Research Studies (14 papers) and Advanced NMR Techniques and Applications (7 papers). David Clayton is often cited by papers focused on Advanced MRI Techniques and Applications (15 papers), Multiple Sclerosis Research Studies (14 papers) and Advanced NMR Techniques and Applications (7 papers). David Clayton collaborates with scholars based in United States, Switzerland and Canada. David Clayton's co-authors include Robert E. Lenkinski, Roland Bammer, Stefan Skare, Rexford D. Newbould, Keith Wheatley, Gregory W. Albers, Angelica Quartino, Scott K. Nagle, Robert Paul and Yong‐Yeon Cho and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

David Clayton

38 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Clayton United States 15 428 322 153 123 104 40 978
Joonmi Oh United States 15 683 1.6× 330 1.0× 143 0.9× 124 1.0× 64 0.6× 31 1.3k
Frank Kober France 25 772 1.8× 353 1.1× 44 0.3× 318 2.6× 93 0.9× 97 2.2k
William Hallett United Kingdom 20 644 1.5× 215 0.7× 47 0.3× 696 5.7× 29 0.3× 55 2.2k
Susan K. Lemieux United States 16 303 0.7× 416 1.3× 49 0.3× 294 2.4× 29 0.3× 21 1.2k
David Raunig United States 18 676 1.6× 157 0.5× 36 0.2× 271 2.2× 38 0.4× 40 1.6k
Pankaj Daga United States 20 315 0.7× 195 0.6× 69 0.5× 372 3.0× 21 0.2× 47 1.3k
Julian C. Matthews United Kingdom 27 1.2k 2.8× 197 0.6× 89 0.6× 308 2.5× 19 0.2× 113 2.4k
Paolo Zanotti‐Fregonara United States 30 1.1k 2.5× 282 0.9× 220 1.4× 534 4.3× 37 0.4× 113 2.8k
Derk D. Purcell United States 14 195 0.5× 522 1.6× 154 1.0× 192 1.6× 10 0.1× 27 1.2k
Andréas H. Jacobs Germany 21 776 1.8× 570 1.8× 90 0.6× 484 3.9× 12 0.1× 51 2.7k

Countries citing papers authored by David Clayton

Since Specialization
Citations

This map shows the geographic impact of David Clayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Clayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Clayton more than expected).

Fields of papers citing papers by David Clayton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Clayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Clayton. The network helps show where David Clayton may publish in the future.

Co-authorship network of co-authors of David Clayton

This figure shows the co-authorship network connecting the top 25 collaborators of David Clayton. A scholar is included among the top collaborators of David Clayton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Clayton. David Clayton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elliott, Colm, Dumitru Fetco, David Araújo, et al.. (2024). Longitudinal Multiparametric Quantitative MRI Evaluation of Acute and Chronic Multiple Sclerosis Paramagnetic Rim Lesions. Journal of Magnetic Resonance Imaging. 61(4). 1812–1828. 2 indexed citations
2.
Krishnan, Anitha Priya, Zhuang Song, David Clayton, et al.. (2023). Multi-arm U-Net with dense input and skip connectivity for T2 lesion segmentation in clinical trials of multiple sclerosis. Scientific Reports. 13(1). 4102–4102. 12 indexed citations
3.
Zivadinov, Robert, Jinglan Pei, David Clayton, et al.. (2023). Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study. Journal of Neurology Neurosurgery & Psychiatry. 95(6). 536–543. 2 indexed citations
4.
Kolind, Shannon, Carolyn Taylor, Roger Tam, et al.. (2022). Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a. NeuroImage Clinical. 35. 103109–103109. 12 indexed citations
5.
6.
Clayton, David, Alexandre Coimbra, Farshid Faraji, et al.. (2021). Resting-state functional magnetic resonance imaging in a randomized clinical trial for Alzheimer's disease. SHILAP Revista de lepidopterología. 1(4). 100055–100055. 1 indexed citations
7.
Guthrie, Heather, Lawrence S. Honig, Helen Lin, et al.. (2020). Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer’s Disease Treated with Escalating Doses for up to 133 Weeks. Journal of Alzheimer s Disease. 76(3). 967–979. 41 indexed citations
8.
Bittner, T., Thomas Duning, Christina Rabe, et al.. (2020). P32 Phase III studies of crenezumab in early (prodromal-to-mild) Alzheimers disease (CREAD/CREAD2): Biomarker results. Clinical Neurophysiology. 131(4). e194–e195. 4 indexed citations
9.
Cummings, Jeffrey L., Sharon Cohen, Christopher H. van Dyck, et al.. (2018). ABBY. Neurology. 90(21). e1889–e1897. 182 indexed citations
10.
Kolind, Shannon, Irene M. Vavasour, Lisa Tang, et al.. (2017). Advanced Myelin-related MRI Measures in Relapsing Multiple Sclerosis Patients treated with Ocrelizumab or Interferon Beta-1a Over 96 Weeks (P6.371). Neurology. 88(16_supplement). 3 indexed citations
11.
Lawrence, J. R., et al.. (2012). Tetanus and the evolution of intensive care in Australia. Critical Care and Resuscitation. 14(4). 316–323. 5 indexed citations
12.
Spielman, Daniel M., et al.. (2008). Can magnetic resonance spectroscopy predict neurodevelopmental outcome in very low birth weight preterm infants?. Journal of Perinatology. 28(9). 611–618. 32 indexed citations
13.
Skare, Stefan, Rexford D. Newbould, David Clayton, et al.. (2007). Clinical multishot DW‐EPI through parallel imaging with considerations of susceptibility, motion, and noise. Magnetic Resonance in Medicine. 57(5). 881–890. 122 indexed citations
14.
Pineda, Angel R., et al.. (2007). SENSE phase‐constrained magnitude reconstruction with iterative phase refinement. Magnetic Resonance in Medicine. 58(5). 910–921. 16 indexed citations
15.
Jochimsen, Thies H., Rexford D. Newbould, Stefan Skare, et al.. (2006). Identifying systematic errors in quantitative dynamic‐susceptibility contrast perfusion imaging by high‐resolution multi‐echo parallel EPI. NMR in Biomedicine. 20(4). 429–438. 28 indexed citations
16.
Clayton, David & Robert E. Lenkinski. (2003). MR Imaging of Sodium in the Human Brain with a Fast Three-Dimensional Gradient-Recalled-Echo Sequence at 4 T. Academic Radiology. 10(4). 358–365. 21 indexed citations
17.
Insko, Erik K., David Clayton, & Mark Elliott. (2002). In Vivo Sodium MR Imaging of the Intervertebral Disk at 4 T. Academic Radiology. 9(7). 800–804. 50 indexed citations
18.
Serrai, Haçène, Lotfi Senhadji, David Clayton, Chun S. Zuo, & Robert E. Lenkinski. (2001). Water Modeled Signal Removal and Data Quantification in Localized MR Spectroscopy Using a Time-Scale Postacquistion Method. Journal of Magnetic Resonance. 149(1). 45–51. 14 indexed citations
19.
Clayton, David, Mark A. Elliott, & Robert E. Lenkinski. (2001). In vivo proton spectroscopy without solvent suppression. Concepts in Magnetic Resonance. 13(4). 260–275. 13 indexed citations
20.
Clayton, David. (2000). Multinuclear magnetic resonance techniques for the study of brain metabolism in vivo. Intensive Care Medicine. 27(5). 859–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joonmi Oh Breakdown of academic impact, for papers by Frank Kober Breakdown of academic impact, for papers by William Hallett Breakdown of academic impact, for papers by Susan K. Lemieux Breakdown of academic impact, for papers by David Raunig Breakdown of academic impact, for papers by Pankaj Daga Breakdown of academic impact, for papers by Julian C. Matthews Breakdown of academic impact, for papers by Paolo Zanotti‐Fregonara Breakdown of academic impact, for papers by Derk D. Purcell Breakdown of academic impact, for papers by Andréas H. Jacobs
Rankless by CCL
2026